Enovis Corp Equity Securities, FV-NI, Unrealized Gain (Loss)
Enovis Corp (ENOV) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $0 for the 9-month period ending 2025-10-03, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2025-11-06
- Enovis Corp equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-10-03 was $0.00.
- Enovis Corp equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-07-04 was $0.00.
- Enovis Corp equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-04-04 was $0.00.
- Enovis Corp equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2024-09-27 was $0.00.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month as first filed | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month |
|---|---|---|---|---|
| 2025-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |
| 2025-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | ||
| 2025-04-04 | $0.00 10-Q · filed 2025-05-08 | |||
| 2024-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | -$11.12M 10-Q · filed 2025-11-06 | |
| 2024-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$11.12M 10-Q · filed 2025-08-07 | ||
| 2024-03-29 | -$11.12M 10-Q · filed 2025-05-08 | |||
| 2023-09-29 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | |||
| 2022-09-30 | -$63.13M 10-Q · filed 2023-11-07 | $72.41M derived: sum of 2 quarters · filed 2023-11-07 | $72.41M 10-Q · filed 2023-11-07 | |
| 2022-07-01 | $135.54M 10-Q · filed 2023-08-03 | $135.50M 10-Q · filed 2022-08-04 | $135.54M 10-Q · filed 2023-08-03 | |
| 2021-10-01 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-07-02 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |